These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16699031)

  • 41. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4(+) and CD8(+) cellular immunity and protective efficacy.
    Mo A; Musselli C; Chen H; Pappas J; Leclair K; Liu A; Chicz RM; Truneh A; Monks S; Levey DL; Srivastava PK
    Vaccine; 2011 Nov; 29(47):8530-41. PubMed ID: 21767588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
    Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL
    J Immunol; 2008 Nov; 181(9):6604-15. PubMed ID: 18941251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
    Lee AJ; Ashkar AA
    Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Frequency of Virus Shedding by Herpes Simplex Virus 2-Infected Guinea Pigs in the Absence of CD4
    Bourne N; Perry CL; Banasik BN; Miller AL; White M; Pyles RB; Schäfer H; Milligan GN
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
    Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections.
    Swiecki M; Wang Y; Gilfillan S; Colonna M
    PLoS Pathog; 2013 Oct; 9(10):e1003728. PubMed ID: 24204273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
    Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons.
    Wald A; Koelle DM; Fife K; Warren T; Leclair K; Chicz RM; Monks S; Levey DL; Musselli C; Srivastava PK
    Vaccine; 2011 Nov; 29(47):8520-9. PubMed ID: 21945262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.
    Zhu J; Peng T; Johnston C; Phasouk K; Kask AS; Klock A; Jin L; Diem K; Koelle DM; Wald A; Robins H; Corey L
    Nature; 2013 May; 497(7450):494-7. PubMed ID: 23657257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
    Svensson A; Nordström I; Sun JB; Eriksson K
    J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Herpes serology for dermatologists.
    Goldman BD
    Arch Dermatol; 2000 Sep; 136(9):1158-61. PubMed ID: 10987876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.
    Halford WP; Geltz J; Messer RJ; Hasenkrug KJ
    PLoS One; 2015; 10(12):e0145228. PubMed ID: 26670699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccines for Herpes Simplex: Recent Progress Driven by Viral and Adjuvant Immunology.
    Sandgren KJ; Truong NR; Smith JB; Bertram K; Cunningham AL
    Methods Mol Biol; 2020; 2060():31-56. PubMed ID: 31617171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.
    Koelle DM; Magaret A; McClurkan CL; Remington ML; Warren T; Teofilovici F; Wald A
    Clin Vaccine Immunol; 2008 May; 15(5):773-82. PubMed ID: 18353920
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes.
    Sheridan BS; Cherpes TL; Urban J; Kalinski P; Hendricks RL
    J Virol; 2009 Mar; 83(5):2237-45. PubMed ID: 19073721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections.
    Risinger C; Sørensen KK; Jensen KJ; Olofsson S; Bergström T; Blixt O
    ACS Infect Dis; 2017 May; 3(5):360-367. PubMed ID: 28238255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10DeltaPK.
    Gyotoku T; Ono F; Aurelian L
    Vaccine; 2002 Jun; 20(21-22):2796-807. PubMed ID: 12034107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estradiol Enhances Antiviral CD4
    Bagri P; Ghasemi R; McGrath JJC; Thayaparan D; Yu E; Brooks AG; Stämpfli MR; Kaushic C
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells.
    Hoshino Y; Pesnicak L; Cohen JI; Straus SE
    J Virol; 2007 Aug; 81(15):8157-64. PubMed ID: 17522198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.